Short Interest in Ion Beam Applications SA (OTCMKTS:IOBCF) Increases By 36.8%

Ion Beam Applications SA (OTCMKTS:IOBCF) was the target of a significant growth in short interest in January. As of January 15th, there was short interest totaling 930 shares, a growth of 36.8% from the December 31st total of 680 shares. Based on an average daily volume of 400 shares, the days-to-cover ratio is presently 2.3 days. Based on an average daily volume of 400 shares, the days-to-cover ratio is presently 2.3 days.

Ion Beam Applications Trading Down 4.6%

Shares of Ion Beam Applications stock traded down $0.87 on Monday, hitting $17.84. 300 shares of the company traded hands, compared to its average volume of 600. Ion Beam Applications has a 12-month low of $10.15 and a 12-month high of $19.00. The company has a 50-day moving average price of $14.64 and a 200 day moving average price of $14.20.

Ion Beam Applications Company Profile

Ion Beam Applications (OTCMKTS: IOBCF) is a Belgium-based medical technology company specializing in the development and deployment of particle therapy solutions for cancer treatment. Founded in 1986 and headquartered in Louvain-la-Neuve, the company is best known for its Proteus® line of proton therapy systems, which are designed to deliver precise, high-energy particle beams that target tumors while sparing healthy tissue. IBA oversees the full project lifecycle, from system design and manufacturing to installation, commissioning, and ongoing service support.

In addition to its flagship proton therapy business, IBA operates a diversified portfolio of technologies for medical and industrial applications.